Literature DB >> 17350093

Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement.

Aiko Suminoe1, Akinobu Matsuzaki, Hiroyoshi Hattori, Yuhki Koga, Eiichi Ishii, Toshiro Hara.   

Abstract

The mRNA contents of matrix metalloproteinase (MMP)-2, MMP-9, tissue inhibitor of MMP (TIMP)-1 and TIMP-2 in leukemia cells from 33 infants with acute lymphoblastic leukemia (ALL) were quantified at initial presentation, and the correlation between their expression and patient clinical characteristics was examined. The mRNA contents of MMP-2 and MMP-9 were not associated with any patient characteristics. Positive correlation was found between hepatosplenomegaly and the MMP-2/TIMP-1 and MMP-2/TIMP-2 ratios (p=0.005 and 0.009) and between CNS involvement and the MMP-2/TIMP-2 ratio (p=0.012). The results suggest that MMP/TIMP balance is closely related to the infiltration of leukemia cells into extramedullary organs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350093     DOI: 10.1016/j.leukres.2007.01.015

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  MicroRNA-144 targets APP to regulate AML1/ETO+ leukemia cell migration via the p-ERK/c-Myc/MMP-2 pathway.

Authors:  Ling Jiang; Wei Meng; Guopan Yu; Changxin Yin; Zhixiang Wang; Libin Liao; Fanyi Meng
Journal:  Oncol Lett       Date:  2019-06-14       Impact factor: 2.967

2.  The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity.

Authors:  Jérôme Devy; Farid Ouchani; Christelle Oudot; Jean Jacques Helesbeux; Enguerran Vanquelef; Stéphanie Salesse; Fanja Rabenoelina; Siana Al-Khara; Isabelle Letinois; Olivier Duval; Laurent Martiny; Emmanuelle Charpentier
Journal:  Invest New Drugs       Date:  2010-03-28       Impact factor: 3.850

3.  Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by MMP-2.

Authors:  Ling Jiang; Guopan Yu; Wei Meng; Zhixiang Wang; Fanyi Meng; Wenli Ma
Journal:  Tumour Biol       Date:  2012-11-23

4.  Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.

Authors:  Saran Feng; Jiannong Cen; Yihong Huang; Hongjie Shen; Li Yao; Yuanyuan Wang; Zixing Chen
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

5.  What role for angiogenesis in childhood acute lymphoblastic leukaemia?

Authors:  P Schneider; I Dubus; F Gouel; E Legrand; J P Vannier; M Vasse
Journal:  Adv Hematol       Date:  2011-11-09

6.  Proteomic analysis of cerebrospinal fluid in pediatric acute lymphoblastic leukemia patients: a pilot study.

Authors:  Linghong Guo; Honghong Ren; Hao Zeng; Yanqiu Gong; Xuelei Ma
Journal:  Onco Targets Ther       Date:  2019-05-17       Impact factor: 4.147

7.  A comparative proteomic study of plasma in Colombian childhood acute lymphoblastic leukemia.

Authors:  Sandra Isabel Calderon-Rodríguez; María Carolina Sanabria-Salas; Adriana Umaña-Perez
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

8.  Anti-metastasis effect of fucoidan from Undaria pinnatifida sporophylls in mouse hepatocarcinoma Hca-F cells.

Authors:  Peisheng Wang; Zhichao Liu; Xianli Liu; Hongming Teng; Cuili Zhang; Lin Hou; Xiangyang Zou
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

9.  Association of MMP-2 (-1306 C>T), MMP-9 (-1562 C>T) Gene Polymorphism and the Formation of the Hematological Malignancies.

Authors:  Kaan Savasoglu; Mehmet Emin Erdal
Journal:  Iran J Public Health       Date:  2016-03       Impact factor: 1.429

10.  MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs.

Authors:  Joshua Kapere Ochieng; Samrat T Kundu; Rakhee Bajaj; B Leticia Rodriguez; Jared J Fradette; Don L Gibbons
Journal:  Oncogene       Date:  2020-09-22       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.